Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
[This article belongs to Volume - 25, Issue - 07]

Measuring the level of Interleukine-17 concentration in psoriasis patients' serum

Millions of people throughout the world are affected by the chronic skin condition psoriasis, characterized by the anomalous spread of keratine cells and the development of erythematous scaly plaques on the skin. Its complex etiology is thought to Includes an unregulated immune system response, and psoriasis is characterized by a complex interaction between immune cells, keratine cells, and various pro-inflammatory mediators within the skin. Many cytokines play pivotal roles in causing Of these, the role of interleukin-17 has emerged as a major player in immune pathogenesis of psoriasis, the aim of this research was measurement level's of concentration of interleukin-17 in the serum of psoriasis with a healthy group, and this can help determine whether there is a relationship between high IL-17 level and clinical symptoms of the disease. The study included 174 people (86) healthy people who worked as a control group, and (88) people who were psoriasis patients, all from the province of Babylon, during a period of three months. ELISA test kits were used to measure the amount of Interleukine-17 concentration in the serum of all patients and the control group. Serum Interleukin-17 levels significantly rise in psoriatic patients at the probability level (P 0.05), while they decline in the control group for the same-criteria rates. According to the results of the current investigation, patients with psoriasis reported greater serum interleukin-17 levels than the control group had.